OWVI One World Ventures Inc (CE)

One World Ventures, Inc. (PINKSHEETS: OWVI) announced that its manufacturing subsidiary Tutamen has applied for and received approval for exclusive distribution of the Eukare® blood glucose monitoring system in Mexico. The application for importation of the system was made with Mexico's Federal Commission for Protection Against Health Risks (COFEPRIS) and has been approved by the Mexican Secretariat of Health. The system is a critical part of the ongoing battle against Type II diabetes which has reached epidemic levels in Mexico. The Eukare® system is Food and Drug Administration (FDA) approved in the U.S. and ISO and CE compliant.

Diabetes in Mexico will have risen 40% by the year 2012, killing over 100,000 Mexicans during that year, according to Jose Angel Cordova Villalobos, Health Secretary, Mexico. The disease is the number one cause of nonobstetric hospitalization in Mexico.

With this approval, One World will create a medical devices division of the company that will focus on the manufacturing and delivery of medical devices to areas where there is opportunity to provide for the underserved. Presently, the major pharmaceutical conglomerates with a much higher cost structure are the primary providers of diabetes testing supplies in Mexico.

"The Eukare System allows us to distribute a quality medical device in a more cost effective manner to people who desperately need the care," CEO Steve Prior said. "We've passed all product and packaging approvals and are ready to move to the next step."

"We are very excited to be establishing yet another income stream for the company and anticipate annual sales of the product to exceed $2 million," Prior explained. "It has been an arduous process getting these approvals. We anticipate shipping into Mexico very soon now that we are complete."

Safe Harbor Statement:

Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. One World Ventures, Inc. undertakes no obligation to update any such statements to reflect actual events.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact: One World Ventures, Inc. USA Tel (+1) 702-789-1088 investors@1worldventures.net www.1worldventures.net